Vittorio Canale

Assistant Professor

Jagiellonian University

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vittorio Canale is an Assistant Professor at Jagiellonian University in Poland. His research primarily focuses on drug discovery and development, particularly in the areas of antidepressant and antimicrobial agents. Recent articles by Dr. Canale explore the potential effects of various chemical compounds on Central Nervous System disorders and drug-resistant bacterial strains. He is actively engaged in advancing the understanding of sulfonamide derivatives and their applications in modern pharmacology.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (14)

Agnieszka Nikiforuk

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

Agata Kuziak

Jagiellonian University

POLAND

View details

Valeria Ciaffaglione

ITALY

View details

Frédéric Lamaty

University of Montpellier

FRANCE

View details

Thomas Brzozowski

profesor

Uniwersytet Jagiellonski Collegium Medicum

POLAND

View details

Séverine Chaumont-Dubel

Assistant professor

University of Montpellier

FRANCE

View details

Christine Courteix

Professor of Physiology

Université Clermont Auvergne

FRANCE

View details

Karolina Klesiewicz

Uniwersytet Jagiellonski Collegium Medicum

POLAND

View details

Andrzej Bojarski

Head of the department

Institute of Pharmacology

POLAND

View details

Paweł Zajdel

professor

Uniwersytet Jagiellonski Collegium Medicum

POLAND

View details

Elżbieta Pękala

Jagiellonian University Medical College

POLAND

View details

Elżbieta Karczewska

Associate professor / PhD, DSc

Uniwersytet Jagiellonski Collegium Medicum

POLAND

View details

Xavier Bantreil

Associate Professor (HDR)

Institut des Biomolécules Max Mousseron

FRANCE

View details

Philippe Marin

University of Montpellier

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vittorio Canale

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

New Quipazine Derivatives Active Against Drug-Resistant Oncogenic <i>Helicobacter pylori</i> Strains with Biofilm

Correction: Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models

Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models

Current development in sulfonamide derivatives to enable CNS-drug discovery

Comparison of greenness and whiteness of selected mechanochemical and solution-based reactions using a new RGBsynt model

Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis

The Constitutive Activity of Spinal 5-HT<sub>6</sub> Receptors Contributes to Diabetic Neuropathic Pain in Rats

Design and synthesis of novel arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria

Multistep Mechanochemical Synthesis of PZ-1190, a Multitarget Antipsychotic Agent

1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT<sub>6</sub>R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties

2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity

Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation

Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States

Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach

A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties

mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment

Collaborators (14)

Agnieszka Nikiforuk

Agata Kuziak

Valeria Ciaffaglione

Frédéric Lamaty

Thomas Brzozowski

Séverine Chaumont-Dubel

Christine Courteix

Karolina Klesiewicz

Andrzej Bojarski

Paweł Zajdel

Elżbieta Pękala

Elżbieta Karczewska

Xavier Bantreil

Philippe Marin

Make your next move.